GlassScriptPhysician profile
David M Gilligan
NPI 1184641045
$14,300.27
in general payments reported to CMS, 2019-2025
24 companies · $464 in 2025
The $464 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $149 · 2021: $113 · 2022: $318 · 2023: $426 · 2024: $12K · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,000.00 |
| Food and Beverage | $1,276.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $12,000.00 | 2024 | Prospera |
| Abbott Laboratories | $560.69 | 2020-2025 | Perclose Prostyle, Perclose Proglide |
| Boston Scientific Corporation | $345.72 | 2019-2025 | Watchman Flx |
| Medtronic Vascular, INC. | $281.21 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $235.26 | 2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $196.60 | 2022-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $171.09 | 2022-2025 | |
| Pfizer INC. | $68.46 | 2021-2023 | |
| Amgen INC. | $61.47 | 2021-2024 | Repatha |
| Kiniksa Pharmaceuticals International, Plc | $51.22 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $40.18 | 2024 | Savvywire, Optowire |
| Janssen Pharmaceuticals, INC | $35.68 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.63 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.17 | 2022-2023 | Lifevest |
| Atricure, INC. | $27.90 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $22.41 | 2023 | Alphavac |
| Bardy Diagnostics, INC. | $20.31 | 2020 | |
| Bridgebio Pharma, INC. | $19.57 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $18.62 | 2023 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $17.59 | 2024 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $16.17 | 2023 | |
| Bard Access Systems, INC. | $15.46 | 2019 | |
| Merck Sharp & Dohme LLC | $13.88 | 2022 | |
| Itamar Medical INC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gilligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.